Loading clinical trials...
Loading clinical trials...
Idiotypic Vaccination for Poor-prognosis Follicular Lymphoma Patients in First Relapse
Conditions
Interventions
Follicular lymphoma, patient-specific, soluble protein idiotype vaccine
Locations
1
Spain
University of Navarra Hospital
Pamplona, Navarre, Spain
Start Date
October 1, 2007
Primary Completion Date
September 1, 2013
Completion Date
September 1, 2022
Last Updated
October 6, 2011
NCT06337318
NCT05006716
NCT06026319
NCT07128641
NCT06510361
NCT01804686
Lead Sponsor
Clinica Universidad de Navarra, Universidad de Navarra
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions